Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 525

1.

Complete Genome Sequences of Three Star-Shaped Bacteria, Stella humosa, Stella vacuolata, and Stella Species ATCC 35155.

Shibai A, Maeda T, Kawada M, Kotani H, Sakata N, Furusawa C.

Microbiol Resour Announc. 2019 Aug 8;8(32). pii: e00719-19. doi: 10.1128/MRA.00719-19.

2.

Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.

Nagano T, Ushijima K, Taga N, Takeuchi M, Kawada MA, Aizawa K, Imai Y, Fujimura A.

Eur J Clin Pharmacol. 2019 Jun 27. doi: 10.1007/s00228-019-02709-x. [Epub ahead of print]

PMID:
31250045
3.

Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report.

Toriu N, Sekine A, Mizuno H, Hasegawa E, Yamanouchi M, Hiramatsu R, Hayami N, Hoshino J, Kawada M, Suwabe T, Sumida K, Sawa N, Takaichi K, Ohashi K, Fujii T, Matoba S, Ubara Y.

Case Rep Oncol. 2019 Jun 4;12(2):391-400. doi: 10.1159/000500716. eCollection 2019 May-Aug.

4.

Increase of 1,25 dihydroxyvitamin D in sarcoidosis patients with renal dysfunction.

Toriu N, Sumida K, Oguro M, Oshima Y, Mizuno H, Hasegawa E, Suwabe T, Kawada M, Ueno T, Hayami N, Sekine A, Hiramatsu R, Yamanouchi M, Hoshino J, Sawa N, Takaichi K, Ohashi K, Kinowaki K, Fujii T, Date R, Ubara Y.

Clin Exp Nephrol. 2019 Jun 25. doi: 10.1007/s10157-019-01760-3. [Epub ahead of print]

PMID:
31240503
5.

Significance of urinary albumin excretion in patients with cast nephropathy
.

Nakagawa R, Imafuku A, Hasegawa E, Mizuno H, Kawada M, Sekine A, Hiramatsu R, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hoshino J, Sawa N, Takaichi K, Wake A, Ohashi K, Fujii T, Ubara Y.

Clin Nephrol. 2019 Aug;92(2):81-88. doi: 10.5414/CN109630.

6.

Arteriovenous fistula-related renal bleeding 5 days after percutaneous renal biopsy.

Shima N, Hayami N, Mizuno H, Kawada M, Sekine A, Sumida K, Hiramatsu R, Yamanouchi M, Hasegawa E, Suwabe T, Hoshino J, Sawa N, Takaichi K, Ohashi K, Fujii T, Minota S, Ubara Y.

CEN Case Rep. 2019 Jun 18. doi: 10.1007/s13730-019-00408-1. [Epub ahead of print]

7.

Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer.

Kato Y, Ohishi T, Yamada S, Itai S, Takei J, Sano M, Nakamura T, Harada H, Kawada M, Kaneko MK.

Monoclon Antib Immunodiagn Immunother. 2019 Aug;38(4):157-161. doi: 10.1089/mab.2019.0017. Epub 2019 Jun 14.

PMID:
31199696
8.

Long-term outcome of biopsy-proven cholesterol crystal embolism.

Toriu N, Sumida K, Mizuno H, Hasegawa E, Suwabe T, Kawada M, Ueno T, Hayami N, Sekine A, Hiramatsu R, Yamanouchi M, Hoshino J, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y.

Clin Exp Nephrol. 2019 Jun 3. doi: 10.1007/s10157-019-01749-y. [Epub ahead of print]

PMID:
31161263
9.

A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4.

Sakoh T, Sekine A, Mori T, Mizuno H, Kawada M, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Suwabe T, Sawa N, Ubara Y, Fujimaru T, Sohara E, Shinichi U, Hoshino J, Takaichi K.

Mol Genet Genomic Med. 2019 Jun;7(6):e705. doi: 10.1002/mgg3.705. Epub 2019 May 1.

10.

Leucinostatin Y: A Peptaibiotic Produced by the Entomoparasitic Fungus Purpureocillium lilacinum 40-H-28.

Momose I, Onodera T, Doi H, Adachi H, Iijima M, Yamazaki Y, Sawa R, Kubota Y, Igarashi M, Kawada M.

J Nat Prod. 2019 May 24;82(5):1120-1127. doi: 10.1021/acs.jnatprod.8b00839. Epub 2019 Apr 24.

PMID:
31017786
11.

Anti-CD133 Monoclonal Antibody CMab-43 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer.

Kato Y, Ohishi T, Yamada S, Itai S, Furusawa Y, Sano M, Nakamura T, Kawada M, Kaneko MK.

Monoclon Antib Immunodiagn Immunother. 2019 Apr;38(2):75-78. doi: 10.1089/mab.2019.0002. Epub 2019 Apr 10.

PMID:
30969150
12.

Potential Anticancer Activity of Auranofin.

Onodera T, Momose I, Kawada M.

Chem Pharm Bull (Tokyo). 2019;67(3):186-191. doi: 10.1248/cpb.c18-00767. Review.

13.

Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History.

Sekine A, Fujimaru T, Hoshino J, Suwabe T, Oguro M, Mizuno H, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Mandai S, Chiga M, Kikuchi H, Ando F, Mori T, Sohara E, Uchida S, Sawa N, Takaichi K, Ubara Y.

Am J Nephrol. 2019;49(3):233-240. doi: 10.1159/000497444. Epub 2019 Feb 28.

PMID:
30820006
14.

Regional outbreak of community-associated methicillin-resistant Staphylococcus aureus ST834 in Japanese children.

Uehara Y, Sasaki T, Baba T, Lu Y, Imajo E, Sato Y, Tanno S, Furuichi M, Kawada M, Hiramatsu K.

BMC Infect Dis. 2019 Jan 9;19(1):35. doi: 10.1186/s12879-018-3646-z.

15.

[Idiopathic Pulmonary Artery Aneurysm].

Fukuoka K, Aizawa K, Sugaya A, Kawada M, Kawahito K.

Kyobu Geka. 2018 Dec;71(13):1088-1091. Japanese.

PMID:
30587748
16.

The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.

Kato Y, Ohishi T, Kawada M, Maekawa N, Konnai S, Itai S, Yamada S, Kaneko MK.

Biochem Biophys Rep. 2018 Nov 24;17:23-26. doi: 10.1016/j.bbrep.2018.11.005. eCollection 2019 Mar.

17.

Factors Influencing Cyst Infection in Autosomal Dominant Polycystic Kidney Disease.

Suwabe T, Ubara Y, Hayami N, Yamanouchi M, Hiramatsu R, Sumida K, Sawa N, Sekine A, Kawada M, Hasegawa E, Hoshino J, Takaichi K.

Nephron. 2019;141(2):75-86. doi: 10.1159/000493806. Epub 2018 Dec 4.

PMID:
30513520
18.

Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis.

Imafuku A, Sawa N, Kawada M, Hiramatsu R, Hasegawa E, Yamanouchi M, Hoshino J, Ubara Y, Takaichi K.

Clin Rheumatol. 2019 Apr;38(4):1039-1046. doi: 10.1007/s10067-018-4372-z. Epub 2018 Nov 27.

PMID:
30483978
19.

Strain-triggered mechanical feedback in self-organizing optic-cup morphogenesis.

Okuda S, Takata N, Hasegawa Y, Kawada M, Inoue Y, Adachi T, Sasai Y, Eiraku M.

Sci Adv. 2018 Nov 21;4(11):eaau1354. doi: 10.1126/sciadv.aau1354. eCollection 2018 Nov.

20.

Immunoglobulin G subclass 3 in ISN/RPL lupus nephritis classification
.

Yabuuchi J, Hoshino J, Mizuno H, Ozawa Y, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hayami N, Yamanouchi M, Hasegawa E, Suwabe T, Sawa N, Fujii T, Ohashi K, Takaichi K, Ubara Y.

Clin Nephrol. 2019 Jan;91(1):32-39. doi: 10.5414/CN109459.

PMID:
30431429
21.

Intervenolin suppresses gastric cancer cell growth through the induction of TSP-1 secretion from fibroblast-like stromal cells.

Yoshida J, Abe H, Watanabe T, Kawada M.

Oncol Lett. 2018 Nov;16(5):6777-6785. doi: 10.3892/ol.2018.9485. Epub 2018 Sep 21.

22.

Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.

Oguro M, Kogure Y, Hoshino J, Ubara Y, Mizuno H, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Takaichi K.

J Nephrol. 2018 Dec;31(6):961-966. doi: 10.1007/s40620-018-0545-8. Epub 2018 Oct 24.

PMID:
30357715
23.

Stereoselective conjugate addition of ketones to alkylidene malonates using thiourea-sulfonamide organocatalyst.

Kawada M, Nakashima K, Hirashima SI, Sakagami T, Koseki Y, Miura T.

Chirality. 2018 Nov;30(11):1215-1224. doi: 10.1002/chir.23015. Epub 2018 Sep 13.

PMID:
30211959
24.

Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus.

Shima N, Sumida K, Kawada M, Sekine A, Yamanouchi M, Hiramatsu R, Hayami N, Hasegawa E, Suwabe T, Hoshino J, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y.

Case Rep Rheumatol. 2018 Aug 15;2018:6305356. doi: 10.1155/2018/6305356. eCollection 2018.

25.

Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice.

Matsumoto Y, Yokoi H, Kimura T, Matsumoto Y, Kawada M, Arae K, Nakae S, Ikeda T, Matsumoto K, Sakurai H, Saito K.

Laryngoscope. 2018 Nov;128(11):E377-E384. doi: 10.1002/lary.27394. Epub 2018 Aug 27.

PMID:
30151920
26.

Resection of mediastinal goiter extending to the carina with use of artificial pneumothorax, two-lung ventilation, and thoracoscopy, with the patient in a prone position.

Hayashi S, Kawada M, Hyakushima N, Saikawa D, Ashitate Y, Suzuki Y, Kawarada Y, Kitashiro S, Tsubota H, Okushiba S.

Gen Thorac Cardiovasc Surg. 2019 Jun;67(6):561-565. doi: 10.1007/s11748-018-0998-7. Epub 2018 Aug 24.

PMID:
30141079
27.

Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2.

Itai S, Yamada S, Kaneko MK, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Furusawa Y, Fukui M, Ohishi T, Kawada M, Harada H, Kato Y.

Biochem Biophys Rep. 2018 Aug 7;15:93-96. doi: 10.1016/j.bbrep.2018.07.008. eCollection 2018 Sep.

28.

Acute Kidney Injury by Renal Hemosiderosis Secondary to Primary Cold Agglutinin Disease Associated with an Excessive Alcohol Intake.

Imafuku A, Yamamoto G, Takemura K, Hasegawa E, Sawa N, Kawada M, Sekine A, Hoshino J, Takaichi K, Fujii T, Ohashi K, Ubara Y.

Intern Med. 2018 Nov 15;57(22):3261-3265. doi: 10.2169/internalmedicine.0710-17. Epub 2018 Jul 6.

29.

Renal-limited Cryoglobulinemic Vasculitis: Two Case Reports.

Toriu N, Sawa N, Oguro M, Mizuno H, Oshima Y, Hasegawa E, Sumida K, Suwabe T, Kawada M, Ueno T, Hayami N, Sekine A, Hiramatsu R, Yamanouchi M, Hoshino J, Takaichi K, Ohashi K, Fujii T, Yanagita M, Ubara Y.

Intern Med. 2018;57(13):1879-1886. doi: 10.2169/internalmedicine.0131-17. Epub 2018 Jul 1.

30.

Microscopic polyangiitis necrotizing glomerulonephritis associated with pregnancy: case with a 20-year clinical course and review of the literature.

Oshima Y, Suwabe T, Marui Y, Hayami N, Hasegawa E, Yamanouchi M, Hiramatsu R, Sumida K, Kawada M, Sekine A, Mizuno H, Oguro M, Hoshino J, Sawa N, Ishii Y, Fujii T, Ohashi K, Takaichi K, Ubara Y.

CEN Case Rep. 2018 Nov;7(2):274-281. doi: 10.1007/s13730-018-0342-1. Epub 2018 Jun 5.

31.

Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.

Itai S, Ohishi T, Kaneko MK, Yamada S, Abe S, Nakamura T, Yanaka M, Chang YW, Ohba SI, Nishioka Y, Kawada M, Harada H, Kato Y.

Oncotarget. 2018 Apr 27;9(32):22480-22497. doi: 10.18632/oncotarget.25132. eCollection 2018 Apr 27.

32.

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report.

Kunizawa K, Hoshino J, Mizuno H, Suwabe T, Sumida K, Kawada M, Yamanouchi M, Sekine A, Hayami N, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Shibata S, Ubara Y.

Case Rep Nephrol Dial. 2018 Mar 28;8(1):62-69. doi: 10.1159/000487921. eCollection 2018 Jan-Apr.

33.

Biomechanical characterization of slope walking using musculoskeletal model simulation.

Kawada M, Hata K, Kiyama R, Maeda T, Yone K.

Acta Bioeng Biomech. 2018;20(1):117-125.

PMID:
29658520
34.

Renal histology in a patient with TAFRO syndrome: a case report.

Mizuno H, Sekine A, Oguro M, Oshima Y, Kawada M, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, Hoshino J, Sawa N, Fujii T, Takaichi K, Ohashi K, Ubara Y.

Hum Pathol. 2018 Dec;82:258-263. doi: 10.1016/j.humpath.2018.03.021. Epub 2018 Apr 4.

35.

First installation of a dual-room IVR-CT system in the emergency room.

Wada D, Nakamori Y, Kanayama S, Maruyama S, Kawada M, Iwamura H, Hayakawa K, Saito F, Kuwagata Y.

Scand J Trauma Resusc Emerg Med. 2018 Mar 5;26(1):17. doi: 10.1186/s13049-018-0484-3.

36.

Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials.

Ohishi T, Inaoka DK, Kita K, Kawada M.

Chem Pharm Bull (Tokyo). 2018;66(3):239-242. doi: 10.1248/cpb.c17-00796.

37.

Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.

Ohishi T, Masuda T, Abe H, Hayashi C, Adachi H, Ohba SI, Igarashi M, Watanabe T, Mimuro H, Amalia E, Inaoka DK, Mochizuki K, Kita K, Shibasaki M, Kawada M.

Helicobacter. 2018 Apr;23(2):e12470. doi: 10.1111/hel.12470. Epub 2018 Feb 28.

PMID:
29488678
38.

TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.

Noda-Narita S, Sumida K, Sekine A, Hoshino J, Mise K, Suwabe T, Hayami N, Yamanouchi M, Ueno T, Mizuno H, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y.

CEN Case Rep. 2018 May;7(1):162-168. doi: 10.1007/s13730-018-0319-0. Epub 2018 Feb 21.

39.

A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.

Hoshino J, Furuichi K, Yamanouchi M, Mise K, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Hayami N, Suwabe T, Sawa N, Hara S, Fujii T, Ohashi K, Kitagawa K, Toyama T, Shimizu M, Takaichi K, Ubara Y, Wada T.

PLoS One. 2018 Feb 6;13(2):e0190923. doi: 10.1371/journal.pone.0190923. eCollection 2018.

40.

Preservation of renal function by intensive glycemic control.

Toriu N, Yamanouchi M, Hiramatsu R, Hayami N, Hoshino J, Sekine A, Kawada M, Hasegawa E, Suwabe T, Sumida K, Ueno T, Sawa N, Ohashi K, Fujii T, Takaichi K, Yanagita M, Kobayasi T, Ubara Y.

Endocrinol Diabetes Metab Case Rep. 2018 Jan 8;2018. pii: 17-0136. doi: 10.1530/EDM-17-0136. eCollection 2018.

41.

Corrigendum: Structures and biological activities of novel 4'-acetylated analogs of chrysomycins A and B.

Wada SI, Sawa R, Iwanami F, Nagayoshi M, Kubota Y, Iijima K, Hayashi C, Shibuya Y, Hatano M, Igarashi M, Kawada M.

J Antibiot (Tokyo). 2017 Dec;70(12):1150. doi: 10.1038/ja.2017.128.

PMID:
29260793
42.

Asymmetric Conjugate Additions of Carbonyl Compounds to Nitroalkenes under Solvent-Free Conditions Using Fluorous Diaminomethylenemalononitrile Organocatalyst.

Hirashima SI, Narushima T, Kawada M, Nakashima K, Hanai K, Koseki Y, Miura T.

Chem Pharm Bull (Tokyo). 2017;65(12):1185-1190. doi: 10.1248/cpb.c17-00596.

43.

Efficacy of isoproterenol for treating amlodipine overdose resulting in bradycardia.

Ebihara T, Morita M, Kawada M, Amano K, Kato F, Nakata Y.

Acute Med Surg. 2017 May 26;4(3):353-357. doi: 10.1002/ams2.284. eCollection 2017 Jul.

44.

The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.

Iwadate D, Hasegawa E, Hoshino J, Hayami N, Sumida K, Yamanouchi M, Sekine A, Kawada M, Hiramatsu R, Suwabe T, Sawa N, Yuasa M, Wake A, Fujii T, Ohashi K, Takaichi K, Ubara Y.

Intern Med. 2018 Mar 1;57(5):701-706. doi: 10.2169/internalmedicine.9263-17. Epub 2017 Nov 1.

45.

Phenazine carboxylic acid and its derivative induce osteoblast differentiation in preosteoblastic MC3T3-E1 cells but adipocyte differentiation in pluripotent mesenchymal C3H10T1/2 cells.

Sakamoto S, Watanabe T, Kohda Y, Iijima M, Sawa R, Okada M, Adachi H, Nishimura Y, Kawada M.

J Antibiot (Tokyo). 2017 Dec;70(12):1146-1149. doi: 10.1038/ja.2017.129. Epub 2017 Oct 25.

PMID:
29066793
46.

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease.

Mizuno H, Hoshino J, Suwabe T, Sumida K, Sekine A, Oshima Y, Oguro M, Kunizawa K, Kawada M, Hiramatsu R, Hayami N, Hasegawa E, Yamanouchi M, Sawa N, Takaichi K, Ubara Y.

Case Rep Nephrol Dial. 2017 Jul 19;7(3):108-111. doi: 10.1159/000477664. eCollection 2017 May-Aug.

47.

Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.

Imafuku A, Sawa N, Sekine A, Kawada M, Hiramatsu R, Yamanouchi M, Hasegawa E, Hayami N, Hoshino J, Ubara Y, Takaichi K.

Clin Exp Nephrol. 2018 Jun;22(3):613-619. doi: 10.1007/s10157-017-1493-7. Epub 2017 Oct 12.

PMID:
29027036
48.

Biological activity of intervenolin analogs with a phenyl substituent.

Abe H, Kawada M, Igarashi M, Ohba SI, Hayashi C, Sakashita C, Watanabe T, Shibasaki M.

J Antibiot (Tokyo). 2017 Oct 11. doi: 10.1038/ja.2017.123. [Epub ahead of print]

PMID:
29018268
49.

Structures and biological activities of novel 4'-acetylated analogs of chrysomycins A and B.

Wada SI, Sawa R, Iwanami F, Nagayoshi M, Kubota Y, Iijima K, Hayashi C, Shibuya Y, Hatano M, Igarashi M, Kawada M.

J Antibiot (Tokyo). 2017 Nov;70(11):1078-1082. doi: 10.1038/ja.2017.99. Epub 2017 Sep 6. Erratum in: J Antibiot (Tokyo). 2017 Dec;70(12 ):1150.

PMID:
28874850
50.

A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2.

Iijima M, Kubota Y, Sawa R, Kubota Y, Hatano M, Igarashi M, Kawada M, Momose I, Takekawa M, Shibasaki M.

J Antibiot (Tokyo). 2017 Sep 6. doi: 10.1038/ja.2017.100. [Epub ahead of print]

PMID:
28874847

Supplemental Content

Loading ...
Support Center